The impact of sesamin, episesamin and sesamolin (sesame lignans) on hepatic gene expression profiles was compared with a DNA microarray. Male Sprague-Dawley rats were fed experimental diets containing 0.2% sesamin, episesamin or sesamolin, and a control diet free of lignans for 15 d. Compared to a lignan-free diet, a diet containing sesamin, episesamin and sesamolin caused 1.5-and 2-fold changes in the expression of 128 and 40, 526 and 152, and 516 and 140 genes, respectively. The lignans modified not only the mRNA levels of many enzymes involved in hepatic fatty acid oxidation, but also those of proteins involved in the transportation of fatty acids into hepatocytes and their organelles, and regulating hepatic concentrations of carnitine, CoA and malonyl-CoA. It is apparent that sesame lignans stimulate hepatic fatty acid oxidation by affecting the gene expression of various proteins regulating hepatic fatty acid metabolism. We also observed that lignans modified the gene expression of various proteins involved in hepatic lipogenesis, cholesterogenesis and glucose metabolism. The changes were generally greater with episesamin and sesamolin than with sesamin. In terms of the amounts accumulated in serum and the liver, the lignans ranked in the order sesamolin, episesamin and sesamin. The differences in bioavailability among these lignans appear to be important to their divergent physiological activities.
Sesame seeds contain compounds known collectively as lignans. Sesamin and sesamolin are fat-soluble, and sesame seeds and their oil contain these two lignans at a ratio of about 2 : 1 ( 1 ). Another major lignan of sesame is sesaminol which exists as glucosides ( 2 ), and is not extractable in oil. In the refining of sesame oil, sesamin is epimerized to form episesamin, and most of the sesamolin is degraded ( 3 ) . The lignan preparation obtained as a by-product of the refining of edible sesame oil therefore consists of sesamin and episesamin at a ratio of 1 : 1. This preparation has been tested for its physiological activity by many investigators. We previously demonstrated that this preparation strongly increased the activity and gene expression of enzymes involved in fatty acid oxidation in the rat liver ( 4 ) . This may account for the serum lipid-lowering effect of this preparation ( 4 -6 ) . We subsequently demonstrated that episesamin ( 7 ) and sesamolin ( 8 ) , compared to sesamin, are much stronger at increasing the activity and gene expression of enzymes involved in fatty acid oxidation.
These results indicate that large differences exist among various lignans in their effect on hepatic fatty acid oxidation. However, no study has simultaneously compared the physiological activities of these three lignans.
The DNA microarray is a powerful tool for genomewide analyses of gene expression patterns. Using DNA microarrays containing about 8,000 probes, Tsuruoka et al. ( 9 ) confirmed our previous finding ( 4 ) that a lignan preparation containing equivalent amounts of sesamin and episesamin strongly increased the mRNA expression of various enzymes involved in fatty acid oxidation in the rat liver. In addition, they showed that it increased the gene expression of aldehyde dehydrogenase 1 family members (Aldh1a1 and 1a7). They suggested that up-regulation of these enzymes may be responsible for the preventive effect of the lignan preparation on the ethanol-induced liver damage observed previously ( 10 ) . As they used a lignan preparation containing both sesamin and episesamin in their experiment, information on different effects of various lignans affecting hepatic gene expression profiles is still lacking. The recent development of DNA microarray technology has enabled the examination of more widespread changes in gene expression profiles. Here, we compared the physiological activity of dietary sesamin, episesamin I DE T et al. and sesamolin in affecting gene expression profiles in the rat liver using a microarray containing more than 30,000 oligonucleotide probes.
MATERIALS AND METHODS

Materials.
Sesamin and episesamin with a purity exceeding 99.5% were kindly provided by Kadoya Sesame Mills Inc., Kagawa, Japan. Sesamolin was extracted and purified from crude sesame oil as described previously ( 8 ) . The purity of this compound was 98.5%. A preparation consisting of equivalent amounts of sesamin and episesamin was donated by Takemoto Oil Co., Aichi, Japan.
Animals and diets. Male Sprague-Dawley rats obtained from Charles River Japan, Kanagawa, Japan, at 4 wk of age were housed individually in animal cages in a room with controlled temperature (20-22˚C), humidity (55-65%), and lighting (lights on from 7:00 to 19:00 h), and fed a commercial non-purified diet (Type NMF, Oriental Yeast Co., Ltd., Tokyo, Japan) for 7 d. After this acclimatization period, animals were divided into 4 groups with equal mean body weights consisting of 7 animals each and fed either a diet free of lignan or diets containing 0.2% lignan (sesamin, episesamin or sesamolin) for 15 d (Expt. 1). In a second experiment (Expt. 2), two groups of rats consisting of 7 animals each were fed either a lignan-free diet or a diet containing 0.2% of a preparation consisting of equivalent amounts of sesamin and episesamin for 15 d. The basal composition of the experimental diet was the same as described previously ( 8 ) . Upon termination of the experimental period, animals were anesthetized using diethyl ether and killed by bleeding from the abdominal aorta, after which livers were excised. This study was approved by the review board of animal ethics of our institute and we followed the institute's guidelines in the care and use of laboratory animals.
Affymetrics GeneChip and GeneSpring analyses. RNA extracted from the livers of 5 rats from each group was subjected to microarray analyses (Expt. 1). Rats with the highest and lowest body weights in each group at the time of killing were eliminated from microarray analyses. RNA was processed using kits supplied by Affymetrix (Santa Clara, CA) to prepare fragmented biotinylated cRNA for hybridization to the Rat Genome 230 2.0 Array. Analyses of the DNA microarray data were performed using GeneSpring GX ver 7.3 software (Agilent Technologies Inc., Santa Clara, CA). Per chip and per gene normalizations were carried out using a 50 percentile value of signal intensity in each chip, and the mean values in rats fed a control diet free of lignan, respectively. After the normalizations, the following filtering criteria were adopted to prepare the gene list for the subsequent analysis to eliminate unreliable data with low signals. First, the expression data had to call more than 10 P-or M-flags according to the Affymetrix algorithm out of 20 measurements. Second, the average signal intensity had to be greater than 100 in at least one of the four treatments. The expression data of 8,904 genes in total survived after these treatments.
Fold changes in the expression of genes in rats fed lignans compared to the value in animals fed a lignan-free diet were evaluated using this gene list.
Real-time PCR quantification of mRNAs. mRNA quantification by real-time PCR was performed as detailed previously ( 11 ) . mRNA abundance was calculated as a ratio to the mRNA abundance of ␤ -actin in each cDNA sample and expressed as a fold-change, assigning a value of 1 for rats fed a diet free of lignan. Nucleotide sequences of forward and reverse primers and probes to detect the mRNAs for the enzymes involved in fatty acid oxidation were the same as described previously ( 8 ) . Those for the other proteins are described in Table 1 .
Analyses of serum and liver components. Liver triacylglycerol, phospholipid and cholesterol concentrations were determined as described ( 4 ) . Serum triacylglycerol, cholesterol, phospholipid, and non-esterified fatty acid concentrations were measured using commercial kits (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Concentrations of lignans in the liver and serum were analyzed by HPLC as detailed previously ( 12 ) . Serum (1 mL) was deproteinized by adding 0.25 mL of 30% perchloric acid (v/v) followed by centrifugation at 12,000 ϫ g for 20 min. The supernatant was neutralized with 3 mol/L K 2 CO 3 . Lactate ( 13 ) and pyruvate ( 14 ) , and acetoacetate ( 15 ) levels in serum extract were determined spectrophotometrically using L -lactate dehydrogenase (Roche Diagnostics K.K., Tokyo, Japan), and 3-hydroxybutyrate dehydrogenase (Roche Diagnostics K.K.), respectively. For the analysis of ␤ -hydroxybutyrate, to 20 L of the serum extract was added 30 L of water and 25 L of a mixture containing 6 mmol/L NAD, 0.3 units/mL of 3-hydroxybutyrate dehydrogenase, 100 mmol/L Tris and 900 mmol/L hydrazine (pH 8.5) to generate NADH. After incubation at room temperature for 1 h, 20 L of the reaction mixture was analyzed by HPLC at a flow rate of 1 mL/min to separate and quantify NADH by monitoring the OD at 340 nm. The mobile phase for HPLC consisted of 80% (v/v) 160 mmol/L ammonium dihydrogen phosphate (pH 6.0) and 20% (v/v) methanol containing 0.65% (v/v) tributylamin. The hepatic concentration of carnitine was analyzed by the method of Pearson et al. ( 16 ) .
Statistical analysis. GeneSpring GX ver 7.3 and StatView for Macintosh (SAS Institute Inc., Cary, NC, USA) were used for the statistical analysis. Data were analyzed with a one-way ANOVA to establish whether the effects of lignans were significant (Expt. 1). Significant differences of the means at a level of p Ͻ 0.05 were evaluated with Tukey's test (Expt. 1) or Student's t -test (Expt. 2).
RESULTS
Serum and liver lipid and lignan concentrations (Expt. 1)
No significant differences in food intake (19.1-20.0 g/d) or growth (83.4-92.2 g/10 d) were seen among the groups. Liver weights were significantly higher in rats given diets containing episesamin and sesamolin than in the animals fed a lignan-free diet. However, sesamin did not affect this parameter (Table  2) . Episesamin and sesamolin, but not sesamin, significantly lowered epididymal white adipose tissue weights. Perirenal white adipose tissue weights tended to be lower in rats given diets containing episesamin and sesamolin than in the animals fed a lignin-free diet. The parameters were comparable between rats fed a diet containing sesamin and a diet free of lignans.
Serum triacylglycerol, free fatty acid and phospholipid concentrations were significantly lower in rats fed the diets containing lignans than in the animals fed a lignan-free diet. Among rats fed lignans, the phospholipid concentration was significantly higher in the ani- The numbers in the space between overlapping circles represent the number of genes that were affected by the lignan species represented by the circles. The numbers in the outer portion of each circle represent the number of genes that were exclusively affected by the specific lignan represented by that particular circle.
mals fed sesamolin than in those fed sesamin and episesamin. However, the values for triacylglycerol and free fatty acid were comparable among rats fed the various lignans. Sesamin and episesamin, but not sesamolin, significantly reduced serum concentrations of cholesterol. Diets containing sesamin and episesamin compared to a lignan-free diet significantly reduced the hepatic concentration of triacylglycerol. However, sesamolin did not reduce this parameter. Hepatic cholesterol concentrations were significantly lower in rats fed lignans than in the animals fed a lignan-free diet, and were comparable among rats fed the various lignans. Dietary lignans significantly increased hepatic concentrations of phospholipid. The values were significantly higher in rats fed episesamin and sesamolin than in the animals fed sesamin. Lignans were not detected in serum or in the liver in rats fed a lignan-free diet. In terms of their concentrations in serum and liver, the lignans ranked in the order sesamolin, episesamin and sesamin.
Lignan-dependent changes in gene expression profiles in the liver (Expt. 1)
In total, 1,049 of 8,904 filtered genes were found to be up-or down-regulated more than 1.5-fold by either sesamin, episesamin or sesamolin. Subsequent one-way ANOVA revealed significant lignan-dependent changes (pϽ0.05) in the expression of 679 genes. The numbers of genes up-or down-regulated by dietary lignans among the 679 selected genes are shown as Venn diagrams (Fig. 1 ). Compared to a lignan-free diet, a diet containing sesamin caused 1.5-and 2-fold changes in the expression of 128 and 40 genes, respectively. More of the genes were affected by episesamin and sesamolin. Episesamin and sesamolin caused 1.5-fold changes in the expression of 526 and 516 genes, respectively. These lignans caused 2-fold changes in the expression of 152 and 140 genes, respectively. Therefore, sesamin was less effective in altering the gene expression profile in the liver than were the other lignans. These diagrams also show that many genes were commonly up-regulated by various lignans. Actually, 93 and 97% of genes up-regulated more than 1.5-and 2-fold, respectively, by sesamin were also up-regulated by one or both of the other lignans. This was the same for episesamin and sesamolin. In addition, examination of the data for the genes classified as those exclusively affected by a specific lignan in Venn diagrams revealed that most of these genes were significantly up-regulated by at least one of the other lignans, though the extent of the increase did not necessarily reach 1.5-or 2.0-fold. Therefore, lignans resembled each other with respect to affecting genes whose expression was up-regulated. The proportions were much lower for the genes down-regulated by lignans. However, detailed analyses indicated that the situation for down-regulated genes was similar to that observed with the up-regulated genes. A subsequent Tukey's test revealed that 89, 92 and 95% of the genes down-regulated more than 1.5-fold by sesamin, episesamin and sesamolin, respectively, were significantly (pϽ0.05) down-regulated by one or both of the other lignans, despite the fact that the extent of the reduction did not necessarily reach 1.5-fold. This was the same for the genes down-regulated more than 2-fold by episesamin and sesamolin, but not sesamin. In fact, 93 and 90% of the genes down-regulated more than 2-fold by episesamin and sesamolin, respectively, were also significantly down-regulated by one or both of the other lignans, although the extent of the changes did not necessarily exceed 2-fold. This evaluation was rather difficult for sesamin because only 9 genes were down-regulated more than 2-fold by this lignan.
The functions of genes significantly up-or down-reg- (4) (5) (6) (7) (8) (9) 12) . Therefore, genes related to lipid metabolism whose expression was up-or down-regulated more than 1.5-fold were selected and are listed in Tables 3, 4 and 5.  Tables 4 and 5 also include the genes related to glucose metabolism. Table 3 lists the mRNA levels of genes for enzymes involved in fatty acid oxidation and proteins involved in the biogenesis of mitochondria and peroxisomes. Dietary lignans increased the gene expression of many mitochondrial and peroxisomal enzymes related to fatty acid oxidation, including those involved in acylcarnitine biosynthesis (Crat, Crot and Cpt1b), the conversion of acylcarnitine to acyl-CoA (Cpt2), ␤-oxidation (Ehhadh, Ech1, Acaa1 and 2, Acox1, Hadha, Hadhb and Acadvl), the auxiliary pathway of ␤-oxidation (Dci, and Decr1 and 2), -oxidation (Cyp4a1; Cyp4a10 and Cyp4a3), and ketogenesis (Acat1 and Hmgcl). In addition, the genes for Pex11a, presumed to play a role in peroxisome membrane biogenesis (17) and for Fxc1, which mediates the import and insertion of hydrophobic membrane proteins into the mitochondrial inner membrane (18) , were activated by lignans. The increases in the expression of various genes listed in this table were stronger with episesamin and sesamolin than with sesamin. However, episesamin and sesamolin were equally effective in increasing the values. Lignans also affected the gene expression of enzymes involved in lipid biosynthesis and glucose metabolism ( Table 4 ). The three lignans decreased the expression of Acaca involved in the biosynthesis of malonyl-CoA to a similar level. In contrast, they increased the expression of Mlycd, which catalyzes the breakdown of malonylCoA. The increases were greater with episesamin and sesamolin than with sesamin. Gene expression levels of enzymes involved in lipid biosynthesis including G6pdx, Gpam, Dgat2 and Ppap2b were also generally lower in rats fed diets containing the lignans than in the animals fed a lignan-free diet, despite that the reductions were not significant in some cases. In contrast, episesamin and sesamolin, but not sesamin, increased the mRNA level of Me1. The lignans decreased the expression of Hmgcr, a rate limiting enzyme in cholesterol biosynthesis, to the same level. Episesamin significantly lowered the expression of some other enzymes involved in cholesterogenesis (Idi1, Sqle and Dhcr24). Sesamolin also significantly reduced the expression of Sqle and Dhcr24. Sesamin was rather ineffective in decreasing these values, and a significant reduction was observed only with Dhcr24. Episesamin and sesamolin, but not sesamin, significantly increased the mRNA expression of Mgll, which may be involved in the hydrolysis of intracellular triacylglycerol (19) , and Pank1, which catalyzes a rate-limiting step in CoA biosynthesis (20) .
All the lignans significantly lowered the gene expression of Pklr and Gpi, enzymes involved in glycolysis. In contrast, episesamin and sesamolin, but not sesamin, increased the expression of Pdk4, which phosphorylates pyruvate dehydrogenase and hence reduces its enzymatic activity.
Lignans affected the gene expression of various transporters involved in lipid and carbohydrate metabolism ( Table 5 ). All the lignans significantly increased the mRNA expression of Slc22a5, which mediates highaffinity sodium-dependent carnitine transport (21) . The increases were stronger with episesamin and sesamolin than with sesamin, and comparable between the two former compounds. Episesamin and sesamolin, but not sesamin, significantly increased the mRNA levels of Slc25a20, which transports acylcarnitine into the mitochondrial matrix. Episesamin and sesamolin increased the mRNA expression of Cd36, a long chain fatty acid transporter located in the plasma membrane. However, sesamin did not cause a significant increase in this parameter. Episesamin and sesamolin, but not sesamin, significantly increased the gene expression of Abcd3, which is involved in the import of fatty acids and/or fatty acyl-CoAs into peroxisomes (22) . The sesamin-dependent change was not significant. With regard to the transporter involved in carbohydrate metabolism, all the lignans significantly decreased the gene expression of Slc2a2, which mediates facilitated bidirectional glucose transport. The extent of the decrease was weaker with sesamin than with episesamin or sesamolin, and comparable between the latter two lignans.
Lignan-dependent changes in the activity and mRNA level of enzymes involved in hepatic fatty acid oxidation and mRNA levels in epididymal adipose tissue (Expt. 1)
We observed divergent physiological activities affecting the gene expression of enzymes involved in hepatic fatty acid oxidation among various lignans using a DNA microarray. We therefore analyzed the activity of enzymes involved in hepatic fatty acid oxidation (Table  6 ). Diets containing episesamin and sesamolin, compared to a lignan-free diet, caused a large increase in the peroxisomal fatty acid oxidation rate and the activities of various enzymes involved in fatty acid oxidation. The peroxisomal fatty acid oxidation rate and 3-hydroxyacyl-CoA dehydrogenase activity were slightly higher in rats fed sesamolin than in those fed episesamin. However, activity levels of the other enzymes were comparable between rats fed episesamin and sesamolin. Sesamin, compared to episesamin and sesamolin, was much less effective in increasing the values. We also analyzed mRNA expression levels of enzymes involved in hepatic fatty acid oxidation by real-time PCR. The results using this methodology were consistent with those obtained with the DNA microarray (Table 3) .
mRNA levels of proteins involved in lipid and carbohydrate metabolism in epididymal white adipose tissue which are highly expressed in this tissue were also analyzed by real-time PCR. Significant lignan-dependent changes were observed in the mRNA levels of all the proteins except Slc2a4 and Fabp4. The lignans caused a 1.6 to 1.7-fold increase in mRNA levels of Scd1. However, the lignan-dependent changes were marginal for the parameters of the other proteins, and did not exceed 1.5-fold.
Metabolic parameters relevant to lipid and glucose metabolism in rats fed a lignan preparation containing sesamin and episesamin (Expt. 2)
The present study using a microarray showed that lignans affected the expression of various genes involved in lipid and glucose metabolism that had not been noticed in previous studies (4, (7) (8) (9) 12 ). An additional experiment was therefore conducted to validate the observations made in this study. Our study indicated that different lignans are similar to each other in affecting the hepatic gene expression profile despite the great diversity in their potency. Therefore, in this experiment, rats were fed a lignan-free diet or a diet with 0.2% of a lignan preparation containing equivalent amounts of sesamin and episesamin. Then, relevant metabolic parameters and mRNA levels of several proteins whose expression was newly identified to be affected by dietary lignans were investigated. In this experiment, mRNA levels were quantified by real-time PCR.
Liver weights were significantly higher in rats given a diet containing lignan than in the animals fed a lignan-free diet ( Table 7) . The lignan preparation significantly lowered serum concentrations of triacylglycerol, cholesterol and phospholipid. However, a significant difference was not found in the serum concentration of free fatty acid between the two groups. The lignan preparation significantly increased serum concentrations of ketone bodies (␤-hydroxybutyrate and acetoacetate). However, it did not affect serum concentrations of glucose, pyruvate and lactate. Lignan did not modify the hepatic concentration of triacylglycerol, but it did reduce that of cholesterol and significantly increased the concentration of phospholipid. The lignan preparation greatly increased the hepatic carnitine concentration.
Real time PCR analyses confirmed the findings obtained by the microarray analysis that lignan increased the mRNA expression of Cd36, Slc22a5, Slc25a20 and Mgll, but decreased that of Slc2a2. Changes ranged within the expected values as observed using the microarray.
DISCUSSION
Using DNA microarray technology, we have confirmed previous findings (4, (7) (8) (9) 12 ) that various lignans increased the gene expression of hepatic enzymes involved in fatty acid oxidation. Moreover, we showed that physiological activities in enhancing gene expression of hepatic enzymes involved in fatty acid oxidation were much stronger with episesamin and sesamolin than with sesamin, and comparable between the former lignans. As lignans increased mRNA levels of Cyp4a1; Cyp4a10 and Cyp4a3, they may also stimulate -oxidation of fatty acids (23, 24) . Since lignans, especially episesamin and sesamolin, up-regulated the gene expression of Fxc1and Pex11a, they may also stimulate the proliferation of mitochondria and peroxisomes. In this study, episesamin and sesamolin but not sesamin increased the liver weight of animals. All the lignans also significantly increased the hepatic phospholipid concentration, and this effect was stronger with episesamin and sesamolin than with sesamin. These observations may represent the consequences of the different effects of various lignans on the proliferation of these organelles.
We observed that lignans, particularly episesamin and sesamolin, affected the expression of not only genes for the enzymes involved in fatty acid oxidation, but also those for various proteins related to fatty acid metabolism as summarized in Fig. 2 . The up-regulation by lignans of the mRNA expression of Cd36 indicated that the compounds increase the hepatic uptake of fatty acid from the blood stream to supply the substrate for fatty acid oxidation. Dietary lignans also increased the gene expression of mitochondrial acylcarnitine transporter (Slc25a20) (25) and peroxisomal fatty acid/acyl-CoA transporter (Abcd3) (22) . These changes should facilitate the delivery of fatty acids into these organelles. It has been suggested that Mgll is involved in complementing the action of lipoprotein lipase and hepatic lipase in degrading triacylglycerol from lipoproteins in the liver (19) . The up-regulation by lignans of Mgll expression may increase the supply of free fatty acid as a substrate for ␤-oxidation.
All the lignans significantly increased the mRNA expression of Slc22a5, and the increases were greater with episesamin and sesamolin than with sesamin. Upregulation in the liver of the expression of this protein is expected to increase the availability of carnitine and hence stimulate mitochondrial transport of fatty acid to be oxidized in this organelle (21) . In fact, we observed an increase in the hepatic carnitine concentration in rats fed a lignan preparation containing both sesamin and episesamin. Episesamin and sesamolin, but not sesamin, caused a significant increase in the expression of Pank1. Therefore, it is expected that these lignans also increase the availability of CoA in the liver to activate fatty acids (20) . All these observations indicated that sesame lignans, especially episesamin and sesamolin, not only up-regulate the gene expression of various enzymes involved in hepatic fatty acid oxidation, but also coordinately modify the expression of various proteins involved in regulating fatty acid transport into hepatocytes and their organelles, as well as the availability of substances required for fatty acid oxidation (carnitine and CoA) to stimulate hepatic fatty acid oxidation. A reduction in hepatic lipogenesis appears to be an alternative mechanism for the lipid-lowering effect of lignans. As various lignans decreased the mRNA expression of Acaca to a similar level, it is thought that they decreased the production of malonyl-CoA as the substrate for lipogenesis to a similar extent. In addition, we observed that lignans increased the mRNA level of Mlycd, which catalyzes the breakdown of malonyl-CoA (26) . We found that the increases were stronger with episesamin and sesamolin than with sesamin. Therefore, it is likely that the availability of malonyl-CoA as a substrate for lipogenesis is lower in rats fed episesamin and sesamolin than in those fed sesamin. Apart from its role as a precursor for fatty acid biosynthesis, malonylCoA plays an important role in regulating hepatic fatty acid oxidation as a potent inhibitor of carnitine palmitoyltransferase I (26) . Therefore, the lignan-dependent changes in the gene expression of Acaca and Mlycd may stimulate mitochondrial transport of fatty acids as substrates for ␤-oxidation. The lignans also lowered the mRNA expression of G6pdx involved in the production of NADPH in cytosols required for fatty acid biosynthesis, even though the reduction observed with sesamolin was not significant. However, episesamin and sesamolin, but not sesamin, significantly increased the mRNA expression of malic enzyme, another enzyme involved in cytosolic NADPH production. This observation is consistent with those observed in rats fed a lignan preparation containing both sesamin and episesamin (4) . Although the changes were not always significant, the lignans lowered the mRNA levels of the enzymes involved in glycerolipid biosynthesis (Gpam, Dgat2 and Ppap2b). Therefore, it is possible that lignans also lower hepatic glycerolipid biosynthesis and hence reduce serum lipid levels. It has been demonstrated that a preparation containing equivalent amounts of sesamin and episesamin reduced the hepatic activity of 3-hydroxy-3-methylglutaryl-CoA reductase, a rate limiting enzyme in cholesterol biosynthesis, in rats (5). Consistent with this observation, various lignans lowered the mRNA expression of this enzyme (Hmgcr) to a similar level in the present study. Moreover, episesamin and sesamolin down-regulated the gene expression of other enzymes involved in cholesterogenesis (Idi1, Sqle and Dhcr24), although the sesamolin-dependent change in Idi1 expression was not statistically significant. Sesamin was much less effective in decreasing these values. Therefore, it is possible that episesamin and sesamolin lower hepatic cholesterogenesis more than sesamin. An increase in the supply of fatty acids and an enhancement of fatty acid oxidation caused by lignans are thought to suppress glycolysis at the step involving pyruvate dehydrogenase due to inhibition of the enzyme's catalytic activity by increased concentrations of acetyl-CoA and NADH in mitochondria (27) . In the present study, lignans affected the mRNA expression of proteins involved in glucose metabolism. Accordingly, lignans reduced the mRNA expression of Slc2a2, alternatively known as glucose transporter 2 (Glut2), which is highly expressed in the liver (28) . In addition, they decreased mRNA levels of enzymes involved in glycolysis (Gpi and Pklr). The activity of pyruvate dehydrogenase is controlled by phosphorylation and dephosphorylation of the enzyme. Pyruvate dehydrogenase kinases (Pdks) phosphorylate pyruvate dehydrogenase and reduce its activity. Episesamin and sesamolin, but not sesamin, more than doubled the gene expression of Pdk4 highly expressed in the liver (29) . Therefore, it is possible that lignans, especially episesamin and sesamolin, lower the rate of glucose oxidation in the liver through reductions both in glucose uptake and in the activity of enzymes involved in glycolysis. The observations made in the present study suggest that dietary lignans affect not only lipid metabolism, but also glucose metabolism in the liver. However, a lignan preparation containing equivalent amounts of sesamin and episesamin did not affect the parameters related to glucose metabolism in serum. Therefore, alterations by lignans of hepatic glucose metabolism may not have a significant role in altering whole body glucose metabolism.
All the changes observed in the expression of various genes related to lipid metabolism are considered to be responsible for the serum lipid-lowering effect of sesame lignans. The extent of the changes was generally greater with episesamin and sesamolin than with sesamin. However, sesamin, episesamin and sesamolin reduced serum lipid levels to almost the same extent. Moreover, hepatic triacylglycerol concentrations were higher in rats fed episesamin and sesamolin than in the animals fed sesamin. This may be ascribable to the different expression levels among the groups of Cd36. The strong up-regulation of Cd36 expression observed in rats fed episesamin and sesamolin may represent metabolic adaptation to supply fatty acid substrate in response to the huge increase in the gene expression of enzymes involved in fatty acid oxidation. However, an increase in the fatty acid supply, if it exceeds the amount that can be handled by fatty acid oxidation, would obligatorily stimulate triacylglycerol synthesis. This may negate the lipid-lowering effect of these lignans. In relation to this consideration, recent studies (11, 30) indicated that the hepatic accumulation of triacylglycerol caused by dietary conjugated linoleic acid was associated with an increase in the mRNA expression of Cd36 in this tissue. Alternatively, alterations in metabolic activity in tissues other than the liver may be responsible for the lignan-dependent changes in lipid levels in serum and liver. Sesamin was weaker than other lignans in affecting the mRNA expression of hepatic proteins involved in lipid metabolism. However, it may strongly affect gene expression in tissues other than the liver and hence affect lipid levels in serum and liver. As adipose tissue is considered to be crucial in regulating whole body lipid and carbohydrate metabolism, we analyzed the mRNA expression of various proteins in epididymal adipose tissue in Expt. 1 by real-time PCR. However, the lignans were rather ineffective in altering the gene expression in this tissue. Therefore, it is difficult to believe that adipose tissue plays a vital role in lignan-dependent changes in lipid metabolism.
Observations of hepatic gene expression profiles in the present study support the idea that various sesame lignans are the natural agonists for peroxisome proliferator-activated receptor ␣ (PPAR␣). Studies have showed that various enzymes involved in fatty acid oxidation located in peroxisomes and mitochondria are up-regulated by PPAR␣ (31) . More recently, information suggests that PPAR␣ agonists affect the expression of diverse genes in addition to the genes related to fatty acid oxidation. Some of the changes may be the result of secondary metabolic events occurring after the activation of PPAR␣. In the present study, we observed that lignans not only up-regulated the gene expression of enzymes involved in fatty acid oxidation, but also affected the expression of many genes involved in lipid and carbohydrate metabolism. The mRNA expression of appreciable numbers of these genes has also been observed to be affected in a similar fashion by various synthetic PPAR␣ agonists in the liver of experimental animals or in cultured hepatocytes (17, 20, 21, 23, 26, (32) (33) (34) . Among the three lignans tested in the present study, episesamin and sesamolin were generally stronger than sesamin in altering the expression of various genes. The binding affinity for, and hence the ability to activate PPAR␣ may be greater for episesamin and sesamolin than for sesamin. However, the observation that liver and serum sesamin levels were much lower than episesamin and sesamolin levels in rats fed the respective lignan raises the possibility that a difference in bioavailability is a crucial factor responsible for the divergent effects of lignans on hepatic gene expression. However, even though twice as much sesamolin as episesamin accumulated in the liver, the impact on hepatic gene expression was comparable between these compounds. Therefore, it is expected that episesamin has a more profound effect on gene expression than sesamolin if these compounds are indistinguishable in terms of bio-availability. With regard to the differences in metabolic fate of various lignans, we examined time-dependent changes in serum concentrations of sesamin, episesamin and sesamolin during a 24-h period after the single oral administration. The lignan concentration increased soon after the administration, peaked at around 7-9 h, and decreased thereafter with half-lives of 4.7Ϯ0.2, 6.1Ϯ0.3 and 7.1Ϯ0.4 h for sesamin, episesamin and sesamolin, respectively (all the differences were significant at pϽ0.05) (Ide et al., unpublished  observation) . Furthermore, the concentrations of these lignans differed at each time point with sesamolin having the highest, sesamin the lowest, and episesamin an intermediate.
It has been demonstrated that sesamin is metabolized to several compounds having the catechol structure in vivo and in vitro by liver microsomes in rats (35) . In the present study, we did not analyze the serum and liver concentrations of these sesamin metabolites in rats fed this lignan. Although a study demonstrating bio-conversion of episesamin and sesamolin is lacking, it is possible that these lignans are also metabolized to compounds distinct in structure from the parent molecules. There is the possibility that these metabolites rather than the parent molecules act as activators of PPAR. Detailed studies on the bio-conversion of various lignans, and examination of the physiological activities of the lignan metabolites are required to draw a definite conclusion regarding the diversity of the effects of lignans on hepatic fatty acid oxidation.
In conclusion, the DNA microarray analysis showed that dietary sesame lignans (sesamin, episesamin and sesamolin) profoundly affect the gene expression profile in the liver. The analysis not only confirmed the previous finding that lignans increased the gene expression of enzymes involved in hepatic fatty acid oxidation, but also showed that they modified the expression of proteins involved in the transportation of fatty acids into hepatocytes and their organelles, and regulate hepatic concentrations of carnitine, CoA and malonyl-CoA. All these changes should facilitate the oxidation of fatty acids in hepatocytes. In addition, we observed that lignans modified the gene expression of various proteins involved in hepatic lipogenesis, cholesterogenesis and glucose metabolism. The changes were generally greater with episesamin and sesamolin than with sesamin. The differences in bio-availability among these lignans appear to be important in terms of the divergent physiological activity of these compounds. However, it also should be stated that differences in bio-availability cannot account for the effects of episesamin and sesamolin on gene expression. This is because the impact on hepatic gene expression profiles was comparable between episesamin and sesamolin, despite the almost two-fold difference in their hepatic accumulation.
